Recent Finacing
Recent Raise
FimmCyte is a preclinical biotech spin‑off from University of Zurich developing non‑hormonal, immune‑reprogramming, disease‑modifying therapies for women's health, with a lead program targeting endometriosis entering IND‑enabling studies.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor